Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $105.6100 (-3.76%) ($105.1400 - $110.2500) on Thu. Apr. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.44% (three month average) | RSI | 41 | Latest Price | $105.6100(-3.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.1% a day on average for past five trading days. | Weekly Trend | LGND declines -3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(60%) IWM(58%) IWC(56%) IWN(56%) | Factors Impacting LGND price | LGND will decline at least -1.72% in a week (0% probabilities). VIXM(-24%) UUP(-20%) VXX(-16%) TBT(-8%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.72% (StdDev 3.44%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $112.19 | 5 Day Moving Average | $106.91(-1.22%) | 10 Day Moving Average | $110.33(-4.28%) | 20 Day Moving Average | $112.19(-5.87%) | To recent high | -15.6% | To recent low | 10.7% | Market Cap | $1.697b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |